Note: this series will no longer be updated. For the latest developments in these markets, please refer to the Neurovascular Device series.

The US market for stroke devices will grow strongly through 2026 as a result of the adoption of innovative devices as well as the establishment of dedicated infrastructure for stroke treatment. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for stroke devices in the US across a 10-year period


The results of the DAWN trial have driven expanded guidelines for the use of neurovascular thrombectomy in the treatment of AIS.

How will the updated guidelines impact market growth?

How much growth is expected in this market?

What factors limit growth of this rapidly expanding market?

An increasing number of small competitors are entering the stroke device market in the US.

How will new entrants change the competitive landscape?

What tactics are smaller companies using to gain share in the market?

Rising adoption of neurovascular thrombectomy procedures for the treatment of AIS is driving infrastructure changes for stroke care in the US.

How will these changes affect the neurovascular thrombectomy device market?

How much will infrastructure growth and change drive the stroke lab system market?

Will the focus on AIS impact interventional hemorrhagic stroke treatments?

Expansion of ICH procedure volumes hinges on obtaining conclusive clinical evidence demonstrating the superior efficacy of neurovascular evacuation devices compared to other treatment options. 

What factors will drive adoption of surgical ICH procedures and devices tailored to those procedures?

Will the reluctance of neurosurgeons to adopt new techniques and devices without strong clinical data impede this market?

How will increasing ICH treatment volumes affect the stroke device market?

Table of contents

  • United States
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Key Report Updates
      • Procedures Covered
      • Products Covered
    • Version History
    • Stroke Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Pricing Strategies and Purchasing Options
        • Clinical Data
        • Physician Training and Marketing
        • Product Improvements and Innovations
      • Market Developments
    • Stroke Lab System Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
    • Acute Ischemic Stroke Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies and Purchasing Options
        • Product Portfolio Management
        • Clinical Data
        • Physician Training and Marketing
        • Product Improvements and Innovations
    • Hemorrhagic Stroke Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
    • Neurovascular Accessory Device Market
      • Market Highlights
      • Market Definitions
        • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Ashish Bhupal, MBA

Ashish Bhupal is a manager within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in clot management, vascular access, aortic repair, heart valve, structural heart, interventional oncology, peripheral vascular, neurovascular, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor's in Biotechnology and an MBA in Biotechnology Management from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution. Follow Ashish on Twitter: @Ashishb_DRG.


Related Reports

Peripheral Vascular Devices | Medtech 360 | Market Insights | Canada

The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product l...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Europe

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the European

View Details

Cardiac Assist Devices | Medtech 360 | Market Insights | Europe

Following the initial impact of the COVID-19 pandemic, the European cardiac assist device market will grow moderately over the forecast period, driv...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | United States

The mature US CRM device market will remain flat through 2028, seeing rising ICM

View Details